medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number S1

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (S1)

Ophthalmic manifestations of COVID-19 and Bases for its ocular transmission

Negrín CY, Cárdenas ML, Lima LCE

Language: Spanish
References: 50
Page:
PDF size: 483.97 Kb.


ABSTRACT

Introduction: COVID-19 is an important global health problem which has been declared pandemic by the World Health Organization. Studies on felines and murines have described cases of conjunctivitis, anterior uveitis, retinitis and optic neuritis. The most common condition in humans is acute viral conjunctivitis; however, its study is still in progress. Research is conducted about coronavirus infection acquired by ocular transmission, the mechanism of which has not been totally clarified.
Objectives: Describe the main ophthalmic manifestations, as well as the role played by ocular surface dynamics and the presence of molecular receptors in SARS-CoV-2 transmission by this route.
Methods: A literature review was conducted of papers published in Spanish or English in the repositories PubMed, Ebsco, Scielo and Google Scholar from 1 January to 31 July 2020. Websites of ophthalmological agencies and associations were also consulted.
Conclusions: Viral conjunctivitis is the main ophthalmic presentation of coronavirus 2019. Although the risk of contagion through tears is low, the transmission mechanism by this route has not been described. Even in the absence of conjunctivitis, SARS-CoV-2 may exist or replicate in the conjunctiva. Ocular protection is therefore advisable.


REFERENCES

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401-2. DOI: https://dx.doi.org/10.1002/jmv.25678

  2. World Health Organization (WHO). Statement on the second meeting of the international health regulations (2005) emergency committee regarding the outbreak of novel coronavirus (2019-nCoV). [acceso 22/04/2020]. Disponible en: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-2.

  3. Salata C, Calistri A, Parolin C, Palù G. Coronaviruses: a paradigm of new emerging zoonotic diseases. Pathog Dis. 2019;77(9):ftaa006. DOI: https://dx.doi.org/10.1093/femspd/ftaa006

  4. World Health Organization (WHO). Los nombres de la enfermedad por coronavirus (COVID-19) y del virus que la causa. [acceso 22/04/2020]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)4.

  5. World Health Organization (WHO). Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. [acceso 22/04/2020]. Disponible en: https://www.who.int/es/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-195.

  6. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report -193. [acceso 22/04/2020]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200731-covid-19-sitrep- 193.pdf?sfvrsn=42a0221d_46.

  7. Ulhaq ZS, Soraya GV. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch Clin Exp Ophthalmol. 2020;258(6):1351-2. DOI: https://dx.doi.org/10.1007/s00417-020-04695-8

  8. Sindhuja K, Lomi N, Asif MI, Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J Ophthalmol. 2020;68(8):1546-50. DOI: https://dx.doi.org/10.4103/ijo.IJO_1319_20

  9. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39. DOI: https://dx.doi.org/10.1016/S0140-6736(20)30313-5

  10. Napoli PE, Nioi M, d'Aloja E, Fossarello M. The Ocular Surface and the Coronavirus Disease 2019: Does a Dual 'Ocular Route' Exist? J Clin Med. 2020;9(5):1269. DOI: https://dx.doi.org/10.3390/jcm9051269

  11. Qing H, Li Z, Yang Z, Shi M, Huang Z, Song J, et al. The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol. 2020;98(3):e388. DOI: https://dx.doi.org/10.1111/aos.14412

  12. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol. 2020;97(4). DOI: https://dx.doi.org/10.1128/JVI.00127-20

  13. Holappa M, Vapaatalo H, Vaajanen A. Many faces of renin-angiotensin system - focus on eye. Open Ophthalmol J. 2017;11(1):122-42. DOI: https://dx.doi.org/10.2174/1874364101711010122

  14. Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocul Immunol Inflamm. 2020 Apr 02;28(3):391-5. DOI: https://dx.doi.org/10.1080/09273948.2020.1738501

  15. Stiles J. Ocular manifestations of feline viral diseases. Vet J. 2014;201(2):166-73. DOI: https://dx.doi.org/10.1016/j.tvjl.2013.11.018

  16. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368-73. DOI: https://dx.doi.org/10.1038/nm1024

  17. Vabret A, Mourez T, Dina J, van der Hoek L, Gouarin S, Petitjean J, et al. Human Coronavirus NL63, France. Emerging Infectious Diseases. 2005;11(8):1225-9. [acceso 22/04/2020]. Disponible en: https://wwwnc.cdc.gov/eid/article/11/8/05-011017.

  18. Zhou Y, Duan C, Zeng Y, Tong Y, Nie Y, Yang Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020;127(7):982-3.

  19. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575-8. DOI: https://dx.doi.org/10.1001/jamaophthalmol. 2020.1291

  20. Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study [published online ahead of print, 2020 May 18]. Acta Ophthalmol. 2020;10:1111/aos.14472. DOI: https://dx.doi.org/10.1111/aos.14472

  21. Ozturker ZK. Conjunctivitis as sole symptom of COVID-19: A case report and review of literature [published online ahead of print, 2020 Jul 24]. Eur J Ophthalmol. 2020;1120672120946287. DOI: https://dx.doi.org/10.1177/1120672120946287

  22. Hu K, Patel J, Patel BC. Ophthalmic Manifestations of Coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Apr 2020. PMID:32310553

  23. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589-94. DOI: https://dx.doi.org/10.1002/jmv.25725

  24. Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18(3):360-2. DOI: https://dx.doi.org/10.1016/j.jtos.2020.03.010

  25. Seah I, Anderson D, Zheng Kang A, Wang L, Rao P, Young BE, et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology. 2020;127(7):977-9. [acceso 22/04/2020]. Disponible en: https://www.aaojournal.org/article/S0161-6420(20)30311-025.

  26. Salducci M, La Torre G. COVID-19 emergency in the cruise's ship: a case report of conjunctivitis. Clin Ter. 2020 May- Jun;171(3):e189-e191. DOI: https://dx.doi.org/10.7417/CT.2020.2212

  27. Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection. Ann Intern Med. 2020;173(3):242-3. DOI: https://dx.doi.org/10.7326/M20-1176

  28. Yan A. Chinese expert who came down with Wuhan coronavirus after saying it was controllable thinks he was infected through his eyes China: South China Morning Post. [publicado 23/01/2020] [acceso 22/04/2020]. Disponible en: https://www.scmp.com/news/china/article/3047394/chinese-expert-who-came-down-wuhan-coronavirus-after-saying-it-was28.

  29. Gangaputra SS, Patel SN. Ocular Symptoms among Nonhospitalized Patients Who Underwent COVID-19 Testing. Ophthalmology. 2020;S0161-6420(20)30574-1. DOI: https://dx.doi.org/10.1016/j.ophtha.2020.06.037

  30. Cheema M, Aghazadeh H, Nazarali S, Zelyas N, Damji KF, Solarte C, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55(4):e125-e129. [acceso 22/04/2020]. Disponible en: https://www.canadianjournalofophthalmology.ca/article/S0008-4182(20)30305-7/30.

  31. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor. Cell. 2020 Apr 16;181(2):271-80. e8. DOI: https://dx.doi.org/10.1016/j.cell.2020.02.052

  32. Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014;88(2):1293-307. DOI: https://dx.doi.org/10.1128/JVI.02202-13

  33. White AJ, Cheruvu SC, Sarris M, Liyanage SS, Lumbers E, Chui J, et al. Expression of classical components of the renin-angiotensin system in the human eye. J Renin Angiotensin Aldosterone Syst. 2015;16(1):59-66. DOI: https://dx.doi.org/10.1177/1470320314549791

  34. Napoli PE, Nioi M, Mangoni L, Gentile P, Braghiroli M, d'Aloja E, et al. Fourier-Domain OCT Imaging of the Ocular Surface and Tear Film Dynamics: A Review of the State of the Art and an Integrative Model of the Tear Behavior During the Inter-Blink Period and Visual Fixation. J Clin Med. 2020;9(3):668. DOI: https://dx.doi.org/10.3390/jcm9030668

  35. Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf. 2020;18(4):537-44. DOI: https://dx.doi.org/10.1016/j.jtos.2020.06.007

  36. Sungnak W, Huang N, Bécavin C, Berg M, Rachel Q, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020 April. [acceso 22/04/2020];26(5):681-7. Disponible en: http://www.nature.com/articles/s41591-020-0868-636.

  37. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552-5. DOI: https://dx.doi.org/10.1002/jmv.25728

  38. American Academy of Ophthalmology Important coronavirus updates for ophthalmologists. 2020 [acceso 22/04/2020]. Disponible en: http://www.aao.org/headline/alert-important-coronavirus-context38.

  39. Gegúndez Fernández JA, Zarranz Ventura J, Garay-Aramburu G, Muñoz Negrete FJ, Mendicute del Barrio J, Pablo Júlvez L, et al. Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavirus COVID-19. Arch Soc Esp Oftalmol. 2020;95:300-10.

  40. Recomendaciones para la atención a pacientes oftalmológicos en relación con emergencia COVID-19. 2020 Mayo [acceso 22/04/2020]. Disponible en: http://www.sefh.es/fichadjuntos/Sociedadesconjuntodef.6_4_2020.pdf.pdf40.

  41. The American Academy of Ophthalmology. Recommendations for urgent and nonurgent patient care. [acceso 22/04/2020]. Disponible en: https://www.aao.org/headline/new- recommendations-urgent-nonurgent-patient-care41.

  42. Consejo Argentino de Oftalmología. COVID-19: Acciones de vigilancia y prevención recomendadas para instituciones y servicios de Oftalmología. [publicado 16/03/2020]. [acceso 22/04/2020]. Disponible en: http://oftalmologos.org.ar/noticias/885-covid-19-acciones-de-vigilancia-y-prevencion-recomendadas-para-instituciones-y-servicios-de-oftalmologia42.

  43. Vargas Peirano M, Navarrete P, Díaz T, Iglesias G, Hoehmann M. Care of ophthalmological patients during the COVID-19 pandemic: A rapid scoping review. Atención de pacientes oftalmológicos durante la pandemia COVID-19: revisión panorámica rápida. Medwave. 2020;20(4):e7902. DOI: https://dx.doi.org/10.5867/medwave.2020.04.7902

  44. Royal College of Ophthalmologists. COVID-19 clinical guidance for ophthalmologists. [acceso 22/04/2020]. Disponible en: http://www.rcophth.ac.uk/wp-content/uploads/2020/03/RCOphth-Management-of-Ophthalmology-Services-during-the-Covid-pandemic-280320.pdf

  45. Sociedad Mexicana de Oftalmología. Recopilación de las recomendaciones para el manejo de pacientes que requieren atención oftalmológica durante la pandemia de SARS-CoV-2. 2020. [acceso 22/04/2020]. Disponible en: http://smo.org.mx/archivos/documentos/2020/Recomendaciones%20COVID-19%20SMO.pdf45.

  46. Lam DSC, Wong RLM, Lai KHW, et al. COVID-19: Special Precautions in Ophthalmic Practice and FAQs on Personal Protection and Mask Selection. Asia Pac J Ophthalmol (Phila). 2020;9(2):67-77. DOI: https://dx.doi.org/10.1097/APO.0000000000000280

  47. Veritti D, Sarao V, Bandello F, Lanzetta P. Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy. Eur J Ophthalmol. 2020;30(4):621-628. DOI: https://dx.doi.org/10.1177/1120672120927865

  48. Ministerio de Salud Pública: Protocolo de Actuación Nacional para la COVID-19. [acceso 22/04/2020]. Disponible en: http://files.sld.cu/editorhome/files/2020/05/MINSAP_Protocolo-de-Actuaci%c3%b3n-Nacional-para-la-COVID-19_versi%c3%b3n-1.4_mayo-2020.pdf

  49. Reed G. In this kind of situation, health as a public good once again becomes paramount, Jeanette Vega MD PhD Member, Global Preparedness Monitoring Board; Chief Medical and Innovation Officer, Red de Salud UC-Christus, Chile. MEDICC Rev. 2020 Apr;22(2):19-20. [acceso 22/04/2020]. Disponible en: http://mediccreview.org/in-this-kind-of-situation-health-as-a-public-good-once-again-becomes-paramount49.

  50. Baird C. Much more visible now are the inequities that have always existed in our system and much clearer the need for stronger state intervention, Armando De Negri Filho MD PhD Collaborating Researcher, UN Research Institute for Social Development; Executive Committee, World Social Forum on Health and Social Security, Brazil. MEDICC Rev. 2020 Apr;22(2):28-30. [acceso 22/04/2020]. Disponible en: https://mediccreview.org/much-more-visible-now-are-the-inequalities-that-have-always-existed-in-our-system-and-much-clearer-the-need-for-stronger-state-intervention50.




2020     |     www.medigraphic.com